Mineralys Therapeutics
MLYS
MLYS
213 hedge funds and large institutions have $2.46B invested in Mineralys Therapeutics in 2026 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 97 increasing their positions, 52 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
16% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 38
17% less funds holding in top 10
Funds holding in top 10: 12 → 10 (-2)
23% less capital invested
Capital invested by funds: $3.21B → $2.46B (-$752M)
Holders
213
Holding in Top 10
10
Calls
$99.9M
Puts
$104M
Top Buyers
| 1 | +$75.5M | |
| 2 | +$31.5M | |
| 3 | +$26.1M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$22.9M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$20.7M |
Top Sellers
| 1 | -$58.1M | |
| 2 | -$47.4M | |
| 3 | -$42.2M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$35M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$29.9M |
